Replimune Group Inc [REPL] stock prices are up 3.00% to $12.01 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The REPL shares have lost -1.72% over the last week, with a monthly amount glided 9.68%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Replimune Group Inc [NASDAQ: REPL] stock has seen the most recent analyst activity on August 28, 2024, when ROTH MKM initiated its Buy rating and assigned the stock a price target of $17. On November 19, 2021, Piper Sandler initiated with a Overweight rating and assigned a price target of $52 on the stock. BTIG Research initiated its recommendation with a Buy and recommended $60 as its price target on November 17, 2020. Jefferies started tracking with a Buy rating for this stock on November 02, 2020, and assigned it a price target of $67. In a note dated October 15, 2020, H.C. Wainwright upgraded an Buy rating on this stock and boosted its target price from $25 to $54.
The stock price of Replimune Group Inc [REPL] has been fluctuating between $4.92 and $17.00 over the past year. Currently, Wall Street analysts expect the stock to reach $19 within the next 12 months. Replimune Group Inc [NASDAQ: REPL] shares were valued at $12.01 at the most recent close of the market. An investor can expect a potential return of 58.2% based on the average REPL price forecast.
Analyzing the REPL fundamentals
Gross Profit Margin for this corporation currently stands at 0.48% with Operating Profit Margin at -57.29%, Pretax Profit Margin comes in at -52.6%, and Net Profit Margin reading is -52.7%. To continue investigating profitability, this company’s Return on Assets is posted at -0.43, Equity is -0.53 and Total Capital is -0.51. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.12.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 11.44 points at the first support level, and at 10.87 for the second support level. However, for the 1st resistance point, the stock is sitting at 12.33, and for the 2nd resistance point, it is at 12.65.
Ratios To Look Out For
It’s worth pointing out that Replimune Group Inc [NASDAQ:REPL]’s Current Ratio is 10.11. Further, the Quick Ratio stands at 10.11, while the Cash Ratio is 2.59.
Transactions by insiders
Recent insider trading involved Patel Sushil, Chief Executive Officer, that happened on Dec 16 ’24 when 10000.0 shares were sold. Chief Strategy Officer, Sushil Patel completed a deal on Dec 16 ’24 to buy 15000.0 shares. Meanwhile, Chief Medical Officer Xynos Konstantinos sold 7246.0 shares on Nov 18 ’24.
